Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Scottish National Investment Bank

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 24
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 20
Rounds per year 6.00
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 2
Key employees Soon

Areas of investment

  • Software
  • Automotive
  • Medical
  • Information Technology
  • Biotechnology

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Scottish National Investment Bank:
Typical Co-investors
Scottish National Investment Bank is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Scottish National Investment Bank:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

EnteroBiotix

Biotechnology
Clinical Trials
Life Science
$31M04 Apr 2024 City of Edinburgh, Scotland, United Kingdom

Cumulus Oncology

Biotechnology
Pharmaceutical
$12M08 Jan 2024 -

R3 IoT Limited

$4M12 Sep 2023 -

Forrit

CMS
Information Technology
Software
$6M12 Apr 2023 Edinburgh, Scotland, United Kingdom

Utopi

Data Integration
Internet of Things
Online Portals
Real Time
Smart Building
$6M31 Mar 2023 Hamilton, Bermuda, United Kingdom

PneumoWave

Artificial Intelligence
Health Care
Health Diagnostics
Home Health Care
Machine Learning
Medical
Medical Device
Sensor
Therapeutics
$10M12 Jan 2023 Glasgow City, Glasgow, United Kingdom

Orbex Space

Aerospace
Autonomous Vehicles
Space Travel
$55M18 Oct 2022 United Kingdom, Scotland, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Scottish National Investment Bank?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 24
Average round size 22M
Rounds per year 6.00
Peak activity year 2023
Lead investments 10
Follow on index 0.17
Exits 2
Group Appearance index 0.46

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

EnteroBiotix

Biotechnology
Clinical Trials
Life Science
$31M04 Apr 2024 City of Edinburgh, Scotland, United Kingdom

Cumulus Oncology

Biotechnology
Pharmaceutical
$12M08 Jan 2024 -

R3 IoT Limited

$4M12 Sep 2023 -

Forrit

CMS
Information Technology
Software
$6M12 Apr 2023 Edinburgh, Scotland, United Kingdom

Utopi

Data Integration
Internet of Things
Online Portals
Real Time
Smart Building
$6M31 Mar 2023 Hamilton, Bermuda, United Kingdom

PneumoWave

Artificial Intelligence
Health Care
Health Diagnostics
Home Health Care
Machine Learning
Medical
Medical Device
Sensor
Therapeutics
$10M12 Jan 2023 Glasgow City, Glasgow, United Kingdom

Orbex Space

Aerospace
Autonomous Vehicles
Space Travel
$55M18 Oct 2022 United Kingdom, Scotland, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: